Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

What is known about atrial fibrillation after a heart transplant

A summary of earlier studies · Arrhythmia & electrophysiology review · Oct 13, 2026

What this means

This is a summary of what is known about irregular heartbeat after heart transplants. It says more research is needed, and that there are no transplant-specific guidelines yet.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inSummary of earlier studies
Who it was tested in
A review of earlier research, not a new study
Kind of research
A summary of earlier studies

The science

Original title
Management of Post-heart Transplant Atrial Fibrillation.
Authors
Abdou M, Sifuentes AA, Goldar G et al.
Journal
Arrhythmia & electrophysiology review
Published
Oct 13, 2026
Study type
Review

Abstract

AF is the most common atrial arrhythmia encountered after orthotopic heart transplantation, with distinct pathophysiology and clinical implications. While early postoperative AF is typically transient, late-onset AF is increasingly recognised as a marker of graft dysfunction, rejection or vasculopathy. Risk factors include advanced recipient age, prolonged ischaemic time and immunosuppressive therapy. The denervated status of the transplanted heart alters typical electrophysiology, complicating diagnosis and management. Management requires individualised strategies balancing rate versus rhythm control, careful drug interaction monitoring and thromboembolic risk assessment. Emerging evidence supports catheter ablation in select cases, although data remain limited. Immunosuppressants, particularly calcineurin inhibitors and azathioprine, may increase AF susceptibility. Given the lack of transplant-specific AF guidelines, a multidisciplinary approach is essential. Improved understanding of AF in orthotopic heart transplantation is critical to optimising graft longevity and patient survival. Future studies are needed to guide evidence-based management and surveillance.

Read it on PubMed ↗

Abdou M, Sifuentes AA, Goldar G et al. Management of Post-heart Transplant Atrial Fibrillation. Arrhythmia & electrophysiology review. 2026. doi:10.15420/aer.2025.45. PMID: 42866112. https://pubmed.ncbi.nlm.nih.gov/42866112/

Report a problem